Although PKCμ and PKCε are known to influence cell proliferation [51-53], our investigations demonstrate a distinct alteration in cell proliferation solely after treatment of renal cancer cells with rottlerin, a PKCδ inhibitor. Here, PRKCE is linked to renal carcinoma.